期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

早期宫颈癌微淋巴转移病理与临床的关系 被引量：4

下载PDF
导出
摘要 目的研究早期宫颈癌微淋巴转移病理与临床关系。方法早期宫颈癌患者44例,采用资料回顾性分析方法 ,研究标本中D2-40、CD105以及VEGF-C在各个宫颈癌临床分期中的表达情况。结果经分期研究,D2-40在0期患者中微淋巴管密度(LMVD)计数为(7.58±1.92)个、Ⅰ期的LMVD计数为(7.06±2.44)个、Ⅱ期的LMVD计数为(5.56±2.43)个;CD105在0期患者中血管密度(MVD)计数为(7.51±1.02)个、Ⅰ期的MVD计数为(8.06±3.91)个、Ⅱ期的MVD计数为(8.72±3.49)个;VEGF-C在0期(+)2例,占20.00%,VEGF-C在Ⅰ期17例,占85.00%,VEGF-C在Ⅱ期9例,占90.00%。结论 D2-40、CD105以及VEGF-C在各个宫颈癌临床分期中的表达显示,其对于宫颈癌患者进行临床诊断具有非常重要的指导意义,值得临床的应用和推广。
作者 纪常生
机构地区 山东即墨市人民医院病理科
出处 《中国实用医药》 2015年第2期76-77,共2页 China Practical Medicine
关键词 宫颈癌 淋巴转移 临床关系
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献12

  • 1张建平,吕卫国,陈怀增,周彩云,谢幸.早期宫颈鳞癌患者微淋巴管的分布及其临床意义[J].中华医学杂志,2005,85(22):1551-1554. 被引量：12
  • 2Akagi K, Ikeda Y, Miyazaki M, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer, 2000 , 83 (7): 887-891
  • 3Banerji S, Jian Ni, Shuxia Wang, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymphspecific receptor for hyaluronan. Cell Biol, 1999, 144 (4) : 789-801
  • 4He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Bionchim Biophys Acta, 2004, 1654:3-12
  • 5Wigle JT, Oliver G. Prox 1 function is required for the development of the murine lymphatic system. Cell, 1999, 98:769-778
  • 6Dumoff KL, Chu C, Xu X, et al. D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol, 2005, 18 (1): 97-104
  • 7Longatto-Filho A, Pinheiro C, Pereira SM, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol, 2007; 107 (1): 45-51
  • 8Orre M , Miri LM , Mamers P, et al. Increased microvessel density in mucinous compared with malignant serous and benign tumors of the ovary. Br J Cancer , 1998 , 77 (12) ; 2204
  • 9Marks A, Sutherland D R, Fley D, et at. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell turnouts. British Cancer, 1999, 80:569-578
  • 10Braun M, Flucke U, Debald M, et al. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat, 2007, 29

共引文献6

同被引文献44

  • 1BurzawaJ, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma[J]. Expert Rev Anticancer Ther, 2015, 15(7):805--810.
  • 2Bartel DP. MicroRNAs: target recognition and regulatory func- tions[J]. Cell, 2009, 136(2):215-233.
  • 3Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J] Clin Oncol, 2009, 27(34):5848-5856.
  • 4Hagman Z, Lame O, Edsj6 A, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions[J]. IntJ Cancer, 2010, 127(12):2768--2776.
  • 5Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing[J]. Cell, 2007, 129(7):1401-1414.
  • 6CanneU IG, Kong YW, Johnston SJ, et al. p38 MAPKJMK2-me- diated induction of miR-34c following DNA damage prevents Myc--dependent DNA replication[J]. Proc Nail Acad Sci U S A, 2010, 107(12):5375-5380.
  • 7Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor sup- pressor in p53-mutant glioma cell line U251[J]. Arch Med Res, 2010, 41(2):67--74.
  • 8Iorio MY, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34):5848--5856.
  • 9Liu F, Wang X, LiJ, et al. miR--34c--3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer[J]. Cell Prolif, 2015, 48(5):582-592.
  • 10Re M, eka A, Rubini CL, et al. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma[J]. Laryngoscope, 2015, 125(9):E306-312.

引证文献4

二级引证文献13

中国实用医药
2015年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部